{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:31:36Z","timestamp":1792690296926,"version":"4.5.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005881","name":"Ministry of Human Capacities","doi-asserted-by":"publisher","award":["20391-3\/2018\/FEKUSTRAT"],"award-info":[{"award-number":["20391-3\/2018\/FEKUSTRAT"]}],"id":[{"id":"10.13039\/501100005881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01406","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T09:17:36Z","timestamp":1561108656000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["The Opposite Effects of Kynurenic Acid and Different Kynurenic Acid Analogs on Tumor Necrosis Factor-\u03b1 (TNF-\u03b1) Production and Tumor Necrosis Factor-Stimulated Gene-6 (TSG-6) Expression"],"prefix":"10.3389","volume":"10","author":[{"given":"Yvette","family":"M\u00e1ndi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9ria","family":"Endr\u00e9sz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timea","family":"Mosolyg\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Buri\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildik\u00f3","family":"Lantos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"F\u00fcl\u00f6p","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Szatm\u00e1ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1lint","family":"L\u0151rinczi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Balog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"V\u00e9csei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00702-011-0681-y","article-title":"The kynurenine system and immunoregulation","volume":"119","author":"M\u00e1ndi","year":"2012","journal-title":"J Neural Transm Vienna Austr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.3389\/fimmu.2017.01957","article-title":"Kynurenic Acid: the janus-faced role of an immunomodulatory tryptophan metabolite and its link to pathological conditions","volume":"8","author":"Wirthgen","year":"2017","journal-title":"Front Immunol."},{"key":"B3","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1523\/JNEUROSCI.10-09-02965.1990","article-title":"Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors","volume":"10","author":"Swartz","year":"1990","journal-title":"J Neurosci Off J Soc Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0165-6147(00)01451-6","article-title":"Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection","volume":"21","author":"Stone","year":"2000","journal-title":"Trends Pharmacol Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1111\/j.1460-9568.2007.05540.x","article-title":"Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats","volume":"25","author":"Stone","year":"2007","journal-title":"Eur J Neurosci."},{"key":"B6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0361-9230(92)90184-Y","article-title":"Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain","volume":"28","author":"V\u00e9csei","year":"1992","journal-title":"Brain Res Bull."},{"key":"B7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: recent advances and new questions","volume":"12","author":"V\u00e9csei","year":"2013","journal-title":"Nat Rev Drug Discov."},{"key":"B8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2217\/14796708.3.2.169","article-title":"L-kynurenine: metabolism and mechanism of neuroprotection","volume":"3","author":"Robotka","year":"2008","journal-title":"Future Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jns.2009.02.326","article-title":"The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection","volume":"283","author":"Vamos","year":"2009","journal-title":"J Neurol Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat Rev Neurosci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","article-title":"The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications","volume":"21","author":"Hilmas","year":"2001","journal-title":"J Neurosci Off J Soc Neurosci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"22021","DOI":"10.1074\/jbc.M603503200","article-title":"Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35","volume":"281","author":"Wang","year":"2006","journal-title":"J Biol Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3389\/fimmu.2014.00458","article-title":"The aryl hydrocarbon receptor meets immunology: friend or foe? A little of both","volume":"5","author":"Julliard","year":"2014","journal-title":"Front Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"973548","DOI":"10.1155\/2015\/973548","article-title":"Endotoxin-induced tryptophan degradation along the kynurenine pathway: the role of indolamine 2,3-dioxygenase and aryl hydrocarbon receptor-mediated immunosuppressive effects in endotoxin tolerance and cancer and its implications for immunoparalysis","volume":"2015","author":"Wirthgen","year":"2015","journal-title":"J Amino Acids."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e11825","DOI":"10.1371\/journal.pone.0011825","article-title":"Psychological stress-induced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans","volume":"5","author":"Kiank","year":"2010","journal-title":"PLoS ONE."},{"key":"B16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5114\/ceji.2016.58815","article-title":"The effect of kynurenic acid on the synthesis of selected cytokines by murine splenocytes - in vitro and ex vivo studies","volume":"41","author":"Ma\u0142aczewska","year":"2016","journal-title":"Cent Eur J Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00210-011-0605-2","article-title":"Different inhibitory effects of kynurenic acid and a novel kynurenic acid analogue on tumour necrosis factor-\u03b1 (TNF-\u03b1) production by mononuclear cells, HMGB1 production by monocytes and HNP1-3 secretion by neutrophils","volume":"383","author":"Tiszlavicz","year":"2011","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"B18","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1083\/jcb.116.2.545","article-title":"A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44","volume":"116","author":"Lee","year":"1992","journal-title":"J Cell Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"25745","DOI":"10.1074\/jbc.M313319200","article-title":"TSG-6 modulates the interaction between hyaluronan and cell surface CD44","volume":"279","author":"Lesley","year":"2004","journal-title":"J Biol Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1242\/jcs.00407","article-title":"TSG-6: a multifunctional protein associated with inflammation","volume":"116","author":"Milner","year":"2003","journal-title":"J Cell Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"19939","DOI":"10.1074\/jbc.M115.710673","article-title":"Tumor necrosis factor-stimulated gene-6 (TSG-6) is constitutively expressed in adult central nervous system (CNS) and associated with astrocyte-mediated glial scar formation following spinal cord injury","volume":"291","author":"Coulson-Thomas","year":"2016","journal-title":"J Biol Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell."},{"key":"B23","first-page":"6593","article-title":"TSG-6: a TNF-, IL-1-, and LPS-inducible secreted glycoprotein associated with arthritis","volume":"151","author":"Wisniewski","year":"1993","journal-title":"J Immunol Baltim Md."},{"key":"B24","doi-asserted-by":"publisher","first-page":"16875","DOI":"10.1073\/pnas.1012451107","article-title":"Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury","volume":"107","author":"Oh","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/scrt68","article-title":"Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-\u03b1-induced protein 6","volume":"2","author":"Danchuk","year":"2011","journal-title":"Stem Cell Res Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"E8151","DOI":"10.1073\/pnas.1614935113","article-title":"TNF\u03b1-stimulated gene-6 (TSG6) activates macrophage phenotype transition to prevent inflammatory lung injury","volume":"113","author":"Mittal","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.matbio.2018.01.011","article-title":"TSG-6: a multifunctional protein with anti-inflammatory and tissue-protective properties","author":"Day","year":"2019","journal-title":"Matrix Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1182\/blood-2010-12-327353","article-title":"Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2\/NF-\u03baB signaling in resident macrophages","volume":"118","author":"Choi","year":"2011","journal-title":"Blood."},{"key":"B29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1006\/cyto.2002.0876","article-title":"Induction of cytokine production by different Staphylococcal strains","volume":"19","author":"Megyeri","year":"2002","journal-title":"Cytokine."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1128\/iai.68.7.3965-3970.2000","article-title":"Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model","volume":"68","author":"Wang","year":"2000","journal-title":"Infect Immun."},{"key":"B31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1469-0691.2008.02130.x","article-title":"Chlamydophila pneumoniae","volume":"15","author":"Blasi","year":"2009","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1086\/379047","article-title":"Infection of U937 monocytic cells with Chlamydia pneumoniae induces extensive changes in host cell gene expression","volume":"188","author":"Virok","year":"2003","journal-title":"J Infect Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.2174\/092986709789909602","article-title":"Syntheses, transformations and pharmaceutical applications of kynurenic acid derivatives","volume":"16","author":"F\u00fcl\u00f6p","year":"2009","journal-title":"Curr Med Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00702-011-0721-7","article-title":"Modifications on the carboxylic function of kynurenic acid","volume":"119","author":"F\u00fcl\u00f6p","year":"2012","journal-title":"J Neural Transm Vienna Austr."},{"key":"B35","unstructured":"F\u00fcl\u00f6pF\n            Szatm\u00e1riI\n            ToldiJ\n            V\u00e9cseiL\n          Novel Types of c-3 Substituted Kinurenic Acid Derivatives With Improved Neuroprotective Activity.2017"},{"key":"B36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mimet.2015.11.010","article-title":"High dynamic range detection of Chlamydia trachomatis growth by direct quantitative PCR of the infected cells","volume":"120","author":"Eszik","year":"2016","journal-title":"J Microbiol Methods."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/s41418-017-0006-2","article-title":"Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells","volume":"25","author":"Wang","year":"2018","journal-title":"Cell Death Differ."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01406\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T20:46:17Z","timestamp":1568925977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01406\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,21]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2019.01406"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01406","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,21]]},"article-number":"1406"}}